These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ; Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897 [TBL] [Abstract][Full Text] [Related]
12. Corticosteroids in Duchenne muscular dystrophy: a reappraisal. Wong BL; Christopher C J Child Neurol; 2002 Mar; 17(3):183-90. PubMed ID: 12026233 [TBL] [Abstract][Full Text] [Related]
13. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy. Connolly AM; Schierbecker J; Renna R; Florence J Neuromuscul Disord; 2002 Dec; 12(10):917-25. PubMed ID: 12467746 [TBL] [Abstract][Full Text] [Related]
14. Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy. Kissel JT; Lynn DJ; Rammohan KW; Klein JP; Griggs RC; Moxley RT; Cwik VA; Brooke MH; Mendell JR Neurology; 1993 Mar; 43(3 Pt 1):532-6. PubMed ID: 8450996 [TBL] [Abstract][Full Text] [Related]
15. Prednisone in Duchenne dystrophy. Dubowitz V Neuromuscul Disord; 1991; 1(3):161-3. PubMed ID: 1822789 [No Abstract] [Full Text] [Related]
16. A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group. Tawil R; McDermott MP; Pandya S; King W; Kissel J; Mendell JR; Griggs RC Neurology; 1997 Jan; 48(1):46-9. PubMed ID: 9008492 [TBL] [Abstract][Full Text] [Related]
17. Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen. ten Dam K; de Groot IJ; Noordam C; van Alfen N; Hendriks JC; Sie LT Neuromuscul Disord; 2012 Jun; 22(6):500-4. PubMed ID: 22390890 [TBL] [Abstract][Full Text] [Related]
18. Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study. Reitter B Brain Dev; 1995; 17 Suppl():39-43. PubMed ID: 8882570 [TBL] [Abstract][Full Text] [Related]
19. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group. Kissel JT; Burrow KL; Rammohan KW; Mendell JR Neurology; 1991 May; 41(5):667-72. PubMed ID: 2027481 [TBL] [Abstract][Full Text] [Related]
20. [For the present Duchenne' disease should not be treated with prednisone]. Jennekens FG; de Visser M; Wintzen AR; Wokke JH Ned Tijdschr Geneeskd; 1996 May; 140(21):1109-11. PubMed ID: 8692335 [No Abstract] [Full Text] [Related] [Next] [New Search]